Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Increasing your income can significantly aid in debt repayment. Discover various ways to boost your earnings and pay off debt.
27,939 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Public sentiment is sharply divided over U.S. action against Iran, with most polls showing more oppose than support. ...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
The healthcare sector is showing unexpected strength, beat-the-market moves, and renewed investor interest. This guid...
Lenders confront tight margins and a data gap that can hide risk. The danger single-bureau blind spot underscores why...
Bank of America signals three quarter-point rate increases in 2026, rattling lenders and borrowers alike. Here’s what...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
Oil jolts can rattle markets fast. This guide explains why oil spikes matter for stocks, what history shows, and acti...
The Pentagon is releasing new files on unidentified phenomena, inviting the public to draw their own conclusions. The...
Stocks rally on the back of a surge in corporate profits, with BEA data showing Q4 2025 profits at $4.35 trillion. Th...
Two energy infrastructure ETFs are under the lens as crude markets stay volatile. EMLP and ENFR continue payouts, but...